• LAST PRICE
    7.0200
  • TODAY'S CHANGE (%)
    Trending Down-0.3200 (-4.3597%)
  • Bid / Lots
    5.0000/ 1
  • Ask / Lots
    10.4800/ 1
  • Open / Previous Close
    7.2450 / 7.3400
  • Day Range
    Low 6.8801
    High 7.6500
  • 52 Week Range
    Low 3.8700
    High 10.7200
  • Volume
    93,323
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 7.34
TimeVolumePRLD
09:32 ET44737.2
09:33 ET2007.19
09:39 ET20006.8801
09:42 ET46007.27
09:50 ET2037.27
09:51 ET2007.2
09:55 ET2007.295
09:57 ET28007.085
10:00 ET3007.28
10:02 ET1007.28
10:04 ET3007.13
10:13 ET4257.3
10:15 ET5007.37
10:18 ET9957.45
10:22 ET8007.485
10:26 ET1007.485
10:27 ET1007.5499
10:36 ET32807.6
10:40 ET7257.6
10:42 ET1007.55
10:44 ET9007.59
10:45 ET4007.61
10:56 ET20407.59
11:00 ET9007.55
11:02 ET62007.45
11:03 ET2007.375
11:18 ET1007.375
11:20 ET3007.38
11:25 ET1007.385
11:59 ET13007.375
12:01 ET21257.4
12:03 ET40717.48
12:08 ET1007.45
12:15 ET2007.46
12:17 ET1007.47
12:19 ET1007.48
12:21 ET30007.49
12:30 ET33357.42
12:39 ET3007.33
01:11 ET47747.16
01:13 ET1007.2
01:15 ET1007.22
01:18 ET5057.15
01:26 ET1007.125
01:27 ET1007.08
01:42 ET1257.11
01:44 ET7007.02
01:45 ET1007.05
01:49 ET18407.055
01:51 ET10337.04
01:54 ET2007.04
01:56 ET1007.04
01:58 ET7007.03
02:00 ET1897.03
02:02 ET6007.06
02:03 ET1257.06
02:05 ET4027.08
02:18 ET11007.03
02:20 ET11006.995
02:23 ET1006.995
02:34 ET4007
02:52 ET4006.98
02:54 ET30937.025
03:06 ET17827.045
03:12 ET1006.975
03:15 ET3006.96
03:26 ET1007
03:28 ET1737.04
03:37 ET5697.02
03:44 ET2007.02
03:55 ET13007.04
03:57 ET3007.04
04:00 ET24007.02
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesPRLD
Prelude Therapeutics Inc
351.3M
-2.8x
---
United StatesTYRA
Tyra Biosciences Inc
350.2M
-6.8x
---
United StatesANNX
Annexon Inc
352.9M
-2.2x
---
United StatesPHVS
Pharvaris NV
324.5M
-5.2x
---
United StatesALDX
Aldeyra Therapeutics Inc
356.0M
-5.5x
---
United StatesVOR
Vor Biopharma Inc
357.3M
-2.3x
---
As of 2023-01-26

Company Information

Prelude Therapeutics Inc. is a clinical-stage fully integrated oncology company built on a foundation of drug discovery to deliver novel precision cancer medicines to underserved patients. The Company’s product candidate pipeline includes PRT543, PRT811, PRT1419, PRT2527, PRT-SCA2 and PRT3645. PRT543 is in a Phase I clinical trial in advanced solid tumors and select myeloid malignancies. PRT811 is a being studied in a Phase I clinical trial in unselected patients with solid tumors, including high-grade glioma. PRT1419 is designed to be a potent and selective inhibitor of the anti-apoptotic protein, MCL1. PRT2527 is designed to be a potent and selective Cyclin-dependent kinase 9 (CDK9), inhibitor. The Company’s drug discovery engine is designed to identify biological targets and create new chemical entities (NCEs). Its pipeline includes six programs, including methyltransferases, kinases, protein-protein interactions and targeted protein degraders.

Contact Information

Headquarters
200 Powder Mill RoadWILMINGTON, DE, United States 19803
Phone
302-467-1280
Fax
302-658-3989

Executives

Independent Chairman of the Board
Paul Friedman
President, Chief Medical Officer
Jane Huang
Chief Executive Officer, Founder, Director
Krishna Vaddi
Chief Financial Officer
Laurent Chardonnet
Executive Vice President, Head of Chemistry
Andrew Combs

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$351.3M
Revenue (TTM)
$0.00
Shares Outstanding
47.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-2.54
Book Value
$6.01
P/E Ratio
-2.8x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.